EMERYVILLE, Calif., Sept. 4, 2012 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide ® compounds for the local non-systemic treatment and prevention of infections, today announced that Tom Paulson, Chief Financial Officer, will present at the Rodman & Renshaw 14th Annual Healthcare Conference held September 9-11, 2012, in New York, NY. Mr. Paulson will be available to respond to questions and to participate in one-on-one meetings with investors attending the conference.
|Event||Rodman & Renshaw 14th Annual Healthcare Conference|
|Date||Monday, September 10, 2012|
|Time||4:30 pm ET|
|Place||The Waldorf=Astoria, New York, NY|